#begin document (en_1032.txt); part 000
en_1032.txt	0	0	Do	VBP	(TOP(SQ*	-	-	-	-	*	-
en_1032.txt	0	1	Antioxidant	NNP	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	Supplements	NNPS	*)	-	-	-	-	*	-
en_1032.txt	0	3	Work	VB	(VP*)	-	-	-	-	*	-
en_1032.txt	0	4	?	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	NIS	UH	(TOP(FRAG(INTJ*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	Serbia	NNP	(NP*)	-	-	-	-	*	-
en_1032.txt	0	3	â€“	SYM	(X*)	-	-	-	-	*	-
en_1032.txt	0	4	The	DT	(S(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	5	influence	NN	*)	-	-	-	-	*	-
en_1032.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	7	diet	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	8	on	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	9	health	NN	(NP*)))))	-	-	-	-	*	(0)
en_1032.txt	0	10	has	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	11	been	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	12	known	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	13	since	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	14	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	15	Ancient	NNP	*	-	-	-	-	*	-
en_1032.txt	0	16	Greeks	NNPS	*))))))	-	-	-	-	*	-
en_1032.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Our	PRP$	(TOP(S(S(NP*	-	-	-	-	*	(2|(1)
en_1032.txt	0	1	bodies	NNS	*)	-	-	-	-	*	2)
en_1032.txt	0	2	simply	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	3	cannot	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	synthesize	VB	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	5	many	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	6	essential	JJ	*	-	-	-	-	*	-
en_1032.txt	0	7	compounds	NNS	*)))))	-	-	-	-	*	-
en_1032.txt	0	8	,	,	*	-	-	-	-	*	-
en_1032.txt	0	9	so	IN	*	-	-	-	-	*	-
en_1032.txt	0	10	our	PRP$	(S(NP*	-	-	-	-	*	(0|(1)
en_1032.txt	0	11	health	NN	*)	-	-	-	-	*	0)
en_1032.txt	0	12	partly	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	13	depends	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	14	on	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	16	we	PRP	(S(NP*)	-	-	-	-	*	(1)
en_1032.txt	0	17	eat	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	19	drink	VBP	*))))))	-	-	-	-	*	-
en_1032.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Antioxidants	NNP	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	3	are	VBP	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	4	believed	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	6	help	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	protect	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	us	PRP	(NP*)	-	-	-	-	*	(1)
en_1032.txt	0	9	against	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	10	both	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	cancer	NN	*	-	-	-	-	*	-
en_1032.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	13	heart	NN	*	-	-	-	-	*	-
en_1032.txt	0	14	disease	NN	*))))))))))	-	-	-	-	*	-
en_1032.txt	0	15	,	,	*)	-	-	-	-	*	-
en_1032.txt	0	16	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	17	one	CD	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	18	such	JJ	*	-	-	-	-	*	-
en_1032.txt	0	19	element	NN	*)	-	-	-	-	*	-
en_1032.txt	0	20	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	21	must	MD	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	22	import	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	23	into	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	24	our	PRP$	(NP*	-	-	-	-	*	(2|(1)
en_1032.txt	0	25	bodies	NNS	*))))))))	-	-	-	-	*	2)
en_1032.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Studies	NNS	(TOP(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	have	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	2	shown	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	4	there	EX	(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	a	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	significant	JJ	*	-	-	-	-	*	-
en_1032.txt	0	8	positive	JJ	*	-	-	-	-	*	-
en_1032.txt	0	9	association	NN	*)	-	-	-	-	*	-
en_1032.txt	0	10	between	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	a	DT	(NP(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	12	higher	JJR	*	-	-	-	-	*	-
en_1032.txt	0	13	intake	NN	*)	-	-	-	-	*	-
en_1032.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	fruits	NNS	(NP*	-	-	-	-	*	-
en_1032.txt	0	16	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	17	vegetables	NNS	*)))	-	-	-	-	*	-
en_1032.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	19	reduced	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	20	risk	NN	*)	-	-	-	-	*	-
en_1032.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	22	chronic	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	23	disease	NN	*)))))))))))	-	-	-	-	*	-
en_1032.txt	0	24	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Fruits	NNS	(TOP(S(S(NP*	-	-	-	-	*	-
en_1032.txt	0	1	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	2	vegetables	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	3	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	sources	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	numerous	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	7	micronutrients	NNS	*)))))	-	-	-	-	*	-
en_1032.txt	0	8	,	,	*	-	-	-	-	*	-
en_1032.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	10	some	DT	(S(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	11	,	,	*	-	-	-	-	*	-
en_1032.txt	0	12	including	VBG	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	b-carotene	NN	(NP(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	14	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1032.txt	0	15	a	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	16	precursor	NN	*)	-	-	-	-	*	-
en_1032.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	18	vitamin	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	19	A	NN	*)))	-	-	-	-	*	-
en_1032.txt	0	20	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1032.txt	0	21	,	,	*	-	-	-	-	*	-
en_1032.txt	0	22	vitamin	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	23	C	NNP	*)	-	-	-	-	*	-
en_1032.txt	0	24	,	,	*	-	-	-	-	*	-
en_1032.txt	0	25	vitamin	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	26	E	NN	*)	-	-	-	-	*	-
en_1032.txt	0	27	,	,	*	-	-	-	-	*	-
en_1032.txt	0	28	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	29	selenium	NN	*)))	-	-	-	-	*	-
en_1032.txt	0	30	,	,	*)	-	-	-	-	*	-
en_1032.txt	0	31	have	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	32	potential	JJ	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	33	as	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	34	antioxidants	NNS	(NP*)))))	-	-	-	-	*	-
en_1032.txt	0	35	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1032.txt	0	1	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	2	specifically	RB	(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	3	makes	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	fruits	NNS	(S(NP*	-	-	-	-	*	-
en_1032.txt	0	5	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	6	vegetables	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	7	so	RB	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	8	beneficial	JJ	*)))))	-	-	-	-	*	-
en_1032.txt	0	9	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	not	RB	*	-	-	-	-	*	-
en_1032.txt	0	11	clear	JJ	(ADJP*))	-	-	-	-	*	-
en_1032.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	(3
en_1032.txt	0	1	main	JJ	*	-	-	-	-	*	-
en_1032.txt	0	2	role	NN	*)	-	-	-	-	*	-
en_1032.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	4	antioxidants	NNS	(NP*)))	-	-	-	-	*	3)
en_1032.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	7	prevent	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	oxidative	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	9	damage	NN	*)	-	-	-	-	*	-
en_1032.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	cellular	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	12	components	NNS	*))))))))	-	-	-	-	*	-
en_1032.txt	0	13	,	,	*	-	-	-	-	*	-
en_1032.txt	0	14	so	IN	*	-	-	-	-	*	-
en_1032.txt	0	15	it	PRP	(S(NP*)	-	-	-	-	*	(3)
en_1032.txt	0	16	has	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	17	been	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	18	proposed	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	19	that	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	20	dietary	JJ	(S(NP*	-	-	-	-	*	-
en_1032.txt	0	21	antioxidants	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	22	decrease	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	23	such	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	24	damage	NN	*)	-	-	-	-	*	-
en_1032.txt	0	25	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	26	with	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	27	it	PRP	(NP*))	-	-	-	-	*	(3)
en_1032.txt	0	28	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	29	risk	NN	*)	-	-	-	-	*	-
en_1032.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	31	disease	NN	(NP*)))))))))))	-	-	-	-	*	-
en_1032.txt	0	32	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	has	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	2	stimulated	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	3	interest	NN	(NP*)	-	-	-	-	*	-
en_1032.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	6	possible	JJ	*	-	-	-	-	*	-
en_1032.txt	0	7	preventive	JJ	*	-	-	-	-	*	-
en_1032.txt	0	8	potential	NN	*)	-	-	-	-	*	-
en_1032.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	10	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	supplements	NNS	*))))))	-	-	-	-	*	-
en_1032.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Indeed	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	consumption	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	4	antioxidant	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	5	supplements	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	7	developed	VBN	(NP*	-	-	-	-	*	(4
en_1032.txt	0	8	countries	NNS	*)))))	-	-	-	-	*	4)
en_1032.txt	0	9	has	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	become	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	11	widespread	JJ	(ADJP*)))	-	-	-	-	*	-
en_1032.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	More	JJR	(TOP(S(NP(NP(QP*	-	-	-	-	*	-
en_1032.txt	0	1	than	IN	*	-	-	-	-	*	-
en_1032.txt	0	2	one-third	NN	*))	-	-	-	-	*	-
en_1032.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	4	adults	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	developed	VBN	(NP*	-	-	-	-	*	(4
en_1032.txt	0	7	countries	NNS	*)))))	-	-	-	-	*	4)
en_1032.txt	0	8	now	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	9	ingest	VBD	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	antioxidant	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	11	pills	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	12	,	,	*	-	-	-	-	*	-
en_1032.txt	0	13	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	14	is	VBZ	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	15	much	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_1032.txt	0	16	easier	JJR	*)	-	-	-	-	*	-
en_1032.txt	0	17	than	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	18	eating	VBG	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	19	fruits	NNS	(NP*	-	-	-	-	*	-
en_1032.txt	0	20	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	21	vegetables	NNS	*))))))))))	-	-	-	-	*	-
en_1032.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	But	CC	(TOP(SQ*	-	-	-	-	*	-
en_1032.txt	0	1	will	MD	*	-	-	-	-	*	-
en_1032.txt	0	2	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	3	benefits	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	6	same	JJ	*))	-	-	-	-	*	-
en_1032.txt	0	7	?	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	As	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	with	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	2	any	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	3	therapeutic	JJ	*	-	-	-	-	*	-
en_1032.txt	0	4	intervention	NN	*)))	-	-	-	-	*	-
en_1032.txt	0	5	,	,	*	-	-	-	-	*	-
en_1032.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	most	RBS	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	8	convincing	JJ	*	-	-	-	-	*	-
en_1032.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	10	direct	JJ	*)	-	-	-	-	*	-
en_1032.txt	0	11	proof	NN	*)	-	-	-	-	*	-
en_1032.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	14	preventive	JJ	*	-	-	-	-	*	-
en_1032.txt	0	15	efficacy	NN	*)	-	-	-	-	*	-
en_1032.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	17	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	18	supplements	NNS	*)))))	-	-	-	-	*	-
en_1032.txt	0	19	requires	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	20	randomized	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	21	,	,	*	-	-	-	-	*	-
en_1032.txt	0	22	controlled	VBN	*	-	-	-	-	*	-
en_1032.txt	0	23	clinical	JJ	*	-	-	-	-	*	-
en_1032.txt	0	24	trials	NNS	*))	-	-	-	-	*	-
en_1032.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Such	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1032.txt	0	1	trials	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	2	eliminate	VBP	(VP(VP*	-	-	-	-	*	-
en_1032.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	4	problems	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	participants	NNS	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	'	POS	*)	-	-	-	-	*	-
en_1032.txt	0	8	dietary	NN	*	-	-	-	-	*	-
en_1032.txt	0	9	record	NN	*))))	-	-	-	-	*	-
en_1032.txt	0	10	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	11	controls	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	13	effects	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	both	DT	(NP(ADJP*	-	-	-	-	*	-
en_1032.txt	0	16	known	JJ	*	-	-	-	-	*	-
en_1032.txt	0	17	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	18	unknown	JJ	*)	-	-	-	-	*	-
en_1032.txt	0	19	confounding	NN	*	-	-	-	-	*	-
en_1032.txt	0	20	factors	NNS	*)))))	-	-	-	-	*	-
en_1032.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	So	RB	(TOP(S(ADVP*	-	-	-	-	*	-
en_1032.txt	0	1	far	RB	*)	-	-	-	-	*	-
en_1032.txt	0	2	,	,	*	-	-	-	-	*	-
en_1032.txt	0	3	many	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	4	studies	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	have	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	been	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	conducted	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	to	TO	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	9	verify	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	11	supposed	JJ	*	-	-	-	-	*	-
en_1032.txt	0	12	beneficial	JJ	*	-	-	-	-	*	-
en_1032.txt	0	13	effects	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	16	supplements	NNS	*)))))))))	-	-	-	-	*	-
en_1032.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	while	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	3	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	4	results	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	epidemiological	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	7	studies	NNS	*)))	-	-	-	-	*	-
en_1032.txt	0	8	have	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	9	been	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	almost	RB	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	11	uniformly	RB	*	-	-	-	-	*	-
en_1032.txt	0	12	positive	JJ	*)))))	-	-	-	-	*	-
en_1032.txt	0	13	,	,	*	-	-	-	-	*	-
en_1032.txt	0	14	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	15	results	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	17	clinical	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	18	trials	NNS	*)))	-	-	-	-	*	-
en_1032.txt	0	19	have	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	20	remained	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	21	largely	RB	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	22	inconclusive	JJ	*)))	-	-	-	-	*	-
en_1032.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Some	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1032.txt	0	1	clinical	JJ	*	-	-	-	-	*	-
en_1032.txt	0	2	trials	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	3	were	VBD	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	terminated	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	prematurely	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	6	because	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	7	harmful	JJ	(S(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	8	effects	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	10	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	supplements	NNS	*)))	-	-	-	-	*	-
en_1032.txt	0	12	were	VBD	(VP*	-	-	-	-	*	-
en_1032.txt	0	13	observed	VBN	(VP*))))))	-	-	-	-	*	-
en_1032.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Indeed	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	3	overwhelming	JJ	*	-	-	-	-	*	-
en_1032.txt	0	4	evidence	NN	*)	-	-	-	-	*	-
en_1032.txt	0	5	currently	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	6	calls	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	into	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	8	question	NN	(NP*))	-	-	-	-	*	-
en_1032.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	10	preventive	JJ	*	-	-	-	-	*	-
en_1032.txt	0	11	effect	NN	*)	-	-	-	-	*	-
en_1032.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	antioxidant	JJ	(NP*	-	-	-	-	*	(5
en_1032.txt	0	14	pills	NNS	*))))	-	-	-	-	*	5)
en_1032.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	On	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	contrary	NN	*))	-	-	-	-	*	-
en_1032.txt	0	3	,	,	*	-	-	-	-	*	-
en_1032.txt	0	4	they	PRP	(NP*)	-	-	-	-	*	(5)
en_1032.txt	0	5	may	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	be	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	harmful	JJ	(ADJP*)	-	-	-	-	*	-
en_1032.txt	0	8	,	,	*	-	-	-	-	*	-
en_1032.txt	0	9	leading	VBG	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	an	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	12	increased	JJ	*	-	-	-	-	*	-
en_1032.txt	0	13	risk	NN	*)	-	-	-	-	*	-
en_1032.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	mortality	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	17	people	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	18	consuming	VBG	(VP*	-	-	-	-	*	-
en_1032.txt	0	19	them	PRP	(NP*))))))))))))	-	-	-	-	*	(5)
en_1032.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	2	several	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	3	possible	JJ	*	-	-	-	-	*	-
en_1032.txt	0	4	explanations	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	negative	JJ	*	-	-	-	-	*	-
en_1032.txt	0	8	effect	NN	*)	-	-	-	-	*	-
en_1032.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	10	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	supplements	NNS	*))))))	-	-	-	-	*	-
en_1032.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	First	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	3	``	``	*	-	-	-	-	*	-
en_1032.txt	0	4	free	JJ	*	-	-	-	-	*	-
en_1032.txt	0	5	radicals	NNS	*	-	-	-	-	*	-
en_1032.txt	0	6	''	''	*)	-	-	-	-	*	-
en_1032.txt	0	7	that	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	8	anti-oxidants	NNS	(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	9	act	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	against	IN	(PP*)))))	-	-	-	-	*	-
en_1032.txt	0	11	perform	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	12	a	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	13	dual	JJ	*	-	-	-	-	*	-
en_1032.txt	0	14	biological	JJ	*	-	-	-	-	*	-
en_1032.txt	0	15	function	NN	*))	-	-	-	-	*	-
en_1032.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Free	JJ	(TOP(S(NP*	-	-	-	-	*	(6
en_1032.txt	0	1	radicals	NNS	*)	-	-	-	-	*	6)
en_1032.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	3	produced	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	continuously	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	all	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	7	cells	NNS	*))	-	-	-	-	*	-
en_1032.txt	0	8	as	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	9	part	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	their	PRP$	(NP*	-	-	-	-	*	(6)
en_1032.txt	0	12	normal	JJ	*	-	-	-	-	*	-
en_1032.txt	0	13	functioning	NN	*))))))	-	-	-	-	*	-
en_1032.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	moderate	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	concentrations	NNS	*))	-	-	-	-	*	-
en_1032.txt	0	3	,	,	*	-	-	-	-	*	-
en_1032.txt	0	4	they	PRP	(NP*)	-	-	-	-	*	(6)
en_1032.txt	0	5	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	essential	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	mediators	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	9	reactions	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	10	by	IN	(SBAR(WHPP*	-	-	-	-	*	-
en_1032.txt	0	11	which	WDT	(WHNP*))	-	-	-	-	*	-
en_1032.txt	0	12	our	PRP$	(S(NP*	-	-	-	-	*	(2|(7)
en_1032.txt	0	13	bodies	NNS	*)	-	-	-	-	*	2)
en_1032.txt	0	14	eliminate	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	15	unwanted	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	16	cells	NNS	*))))))))	-	-	-	-	*	-
en_1032.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	By	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	eliminating	VBG	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	2	free	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	3	radicals	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	4	from	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	5	our	PRP$	(NP*	-	-	-	-	*	(7)
en_1032.txt	0	6	body	NN	*)))))	-	-	-	-	*	-
en_1032.txt	0	7	,	,	*	-	-	-	-	*	-
en_1032.txt	0	8	we	PRP	(NP*)	-	-	-	-	*	(7)
en_1032.txt	0	9	interfere	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	with	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	important	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	12	defensive	JJ	*	-	-	-	-	*	-
en_1032.txt	0	13	mechanisms	NNS	*))	-	-	-	-	*	-
en_1032.txt	0	14	for	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	15	eliminating	VBG	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	16	damaged	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	17	cells	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	18	,	,	*	-	-	-	-	*	-
en_1032.txt	0	19	including	VBG	(PP*	-	-	-	-	*	-
en_1032.txt	0	20	cancerous	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	21	cells	NNS	*)))))))	-	-	-	-	*	-
en_1032.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	So	IN	(TOP(S*	-	-	-	-	*	-
en_1032.txt	0	1	antioxidant	NN	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	substances	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	3	can	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	4	also	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	5	harm	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	people	NNS	(NP*)))	-	-	-	-	*	-
en_1032.txt	0	7	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Whereas	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1032.txt	0	1	our	PRP$	(S(NP*	-	-	-	-	*	(7)
en_1032.txt	0	2	diets	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	3	typically	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	4	contain	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	safe	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	6	levels	NNS	*))))	-	-	-	-	*	-
en_1032.txt	0	7	,	,	*	-	-	-	-	*	-
en_1032.txt	0	8	highly	RB	(NP(ADJP*	-	-	-	-	*	-
en_1032.txt	0	9	concentrated	VBN	*)	-	-	-	-	*	-
en_1032.txt	0	10	antioxidant	JJ	*	-	-	-	-	*	-
en_1032.txt	0	11	supplements	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	12	can	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	13	be	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	14	hazardous	JJ	(ADJP*)))	-	-	-	-	*	-
en_1032.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	fact	NN	(NP*))	-	-	-	-	*	-
en_1032.txt	0	2	,	,	*	-	-	-	-	*	-
en_1032.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	4	amounts	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	antioxidants	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	7	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1032.txt	0	8	lend	VBP	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	9	protection	NN	(NP*)))))))	-	-	-	-	*	-
en_1032.txt	0	10	are	VBP	(VP(VP*	-	-	-	-	*	-
en_1032.txt	0	11	not	RB	*	-	-	-	-	*	-
en_1032.txt	0	12	known	VBN	(VP*))	-	-	-	-	*	-
en_1032.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	14	probably	RB	(VP(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	15	differ	VBP	*	-	-	-	-	*	-
en_1032.txt	0	16	among	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	17	individuals	NNS	(NP*))))	-	-	-	-	*	-
en_1032.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	People	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	exposed	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	2	to	TO	(PP*	-	-	-	-	*	-
en_1032.txt	0	3	increased	VBN	(NP*	-	-	-	-	*	-
en_1032.txt	0	4	oxidative	JJ	*	-	-	-	-	*	-
en_1032.txt	0	5	stress	NN	*))))	-	-	-	-	*	-
en_1032.txt	0	6	may	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	have	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	elevated	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	9	antioxidant	NN	*	-	-	-	-	*	-
en_1032.txt	0	10	requirements	NNS	*)))	-	-	-	-	*	-
en_1032.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	antioxidant	JJ	(NP(NP*	-	-	-	-	*	(8
en_1032.txt	0	3	supplements	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	5	pills	NNS	(NP*)))	-	-	-	-	*	8)
en_1032.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	synthetic	JJ	(ADJP(ADJP*)	-	-	-	-	*	-
en_1032.txt	0	8	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	9	biochemically	RB	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	10	unbalanced	JJ	*))	-	-	-	-	*	-
en_1032.txt	0	11	compared	VBN	(PP*	-	-	-	-	*	-
en_1032.txt	0	12	to	TO	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	their	PRP$	(NP*	-	-	-	-	*	(8)
en_1032.txt	0	14	naturally	RB	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	15	occurring	VBG	*)	-	-	-	-	*	-
en_1032.txt	0	16	counterparts	NNS	*))))	-	-	-	-	*	-
en_1032.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Nor	CC	(TOP(SINV*	-	-	-	-	*	-
en_1032.txt	0	1	are	VBP	*	-	-	-	-	*	-
en_1032.txt	0	2	they	PRP	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	3	subjected	VBN	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_1032.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	6	same	JJ	*	-	-	-	-	*	-
en_1032.txt	0	7	rigorous	JJ	*	-	-	-	-	*	-
en_1032.txt	0	8	toxicity	NN	*	-	-	-	-	*	-
en_1032.txt	0	9	studies	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	10	as	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	11	other	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	12	pharmaceutical	JJ	*	-	-	-	-	*	-
en_1032.txt	0	13	agents	NNS	*))))))	-	-	-	-	*	-
en_1032.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Indeed	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	1	,	,	*	-	-	-	-	*	-
en_1032.txt	0	2	we	PRP	(NP*)	-	-	-	-	*	(9)
en_1032.txt	0	3	still	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	4	lack	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	substantial	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	6	information	NN	*)	-	-	-	-	*	-
en_1032.txt	0	7	on	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	8	how	WRB	(SBAR(SBAR(WHADVP*)	-	-	-	-	*	-
en_1032.txt	0	9	our	PRP$	(S(NP*	-	-	-	-	*	(2|(9)
en_1032.txt	0	10	bodies	NNS	*)	-	-	-	-	*	2)
en_1032.txt	0	11	metabolize	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	12	them	PRP	(NP*))))	-	-	-	-	*	(2)
en_1032.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	14	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1032.txt	0	15	they	PRP	(S(NP*)	-	-	-	-	*	(2)
en_1032.txt	0	16	interact	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	18	one	CD	(NP*	-	-	-	-	*	-
en_1032.txt	0	19	another	DT	*)))))))))	-	-	-	-	*	-
en_1032.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	As	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	a	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	result	NN	*))	-	-	-	-	*	-
en_1032.txt	0	3	,	,	*	-	-	-	-	*	-
en_1032.txt	0	4	it	PRP	(NP*)	-	-	-	-	*	(10)
en_1032.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	still	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	7	unclear	JJ	(ADJP*)	-	-	-	-	*	-
en_1032.txt	0	8	whether	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	9	dosage	NN	(S(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	10	,	,	*	-	-	-	-	*	-
en_1032.txt	0	11	duration	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	use	NN	(NP*)))	-	-	-	-	*	-
en_1032.txt	0	14	,	,	*	-	-	-	-	*	-
en_1032.txt	0	15	or	CC	*	-	-	-	-	*	-
en_1032.txt	0	16	parallel	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	17	intake	NN	*)	-	-	-	-	*	-
en_1032.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	19	other	JJ	(NP*	-	-	-	-	*	(11
en_1032.txt	0	20	agents	NNS	*))))	-	-	-	-	*	11)
en_1032.txt	0	21	determine	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	22	differences	NNS	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	23	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	24	their	PRP$	(NP*	-	-	-	-	*	(11)
en_1032.txt	0	25	effect	NN	*)))))))	-	-	-	-	*	-
en_1032.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_1032.txt	0	1	also	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	3	unclear	JJ	(ADJP*	-	-	-	-	*	-
en_1032.txt	0	4	whether	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	5	oxidative	JJ	(S(NP*	-	-	-	-	*	-
en_1032.txt	0	6	stress	NN	*)	-	-	-	-	*	-
en_1032.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	a	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	9	primary	JJ	*	-	-	-	-	*	-
en_1032.txt	0	10	cause	NN	*)	-	-	-	-	*	-
en_1032.txt	0	11	or	CC	*	-	-	-	-	*	-
en_1032.txt	0	12	a	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	13	secondary	JJ	*	-	-	-	-	*	-
en_1032.txt	0	14	phenomenon	NN	*)	-	-	-	-	*	-
en_1032.txt	0	15	of	IN	(PP(PP*	-	-	-	-	*	-
en_1032.txt	0	16	chronic	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	17	diseases	NNS	*))	-	-	-	-	*	-
en_1032.txt	0	18	,	,	*	-	-	-	-	*	-
en_1032.txt	0	19	as	RB	(CONJP*	-	-	-	-	*	-
en_1032.txt	0	20	well	RB	*	-	-	-	-	*	-
en_1032.txt	0	21	as	IN	*)	-	-	-	-	*	-
en_1032.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	23	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	24	aging	VBG	*	-	-	-	-	*	-
en_1032.txt	0	25	process	NN	*))))))))))	-	-	-	-	*	-
en_1032.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	most	RBS	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	human	JJ	*	-	-	-	-	*	-
en_1032.txt	0	3	disease	NN	*))	-	-	-	-	*	-
en_1032.txt	0	4	,	,	*	-	-	-	-	*	-
en_1032.txt	0	5	oxidative	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	6	stress	NN	*)	-	-	-	-	*	-
en_1032.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	8	merely	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	9	a	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	10	symptom	NN	*))	-	-	-	-	*	-
en_1032.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	So	IN	(TOP(S*	-	-	-	-	*	-
en_1032.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	2	link	NN	*)	-	-	-	-	*	-
en_1032.txt	0	3	between	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	4	oxidative	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	5	stress	NN	*	-	-	-	-	*	-
en_1032.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	7	disease	NN	*)))	-	-	-	-	*	-
en_1032.txt	0	8	should	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	9	not	RB	*	-	-	-	-	*	-
en_1032.txt	0	10	be	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	11	overemphasized	VBN	(VP*)))	-	-	-	-	*	-
en_1032.txt	0	12	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	2	still	RB	(ADVP*)	-	-	-	-	*	-
en_1032.txt	0	3	many	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	4	gaps	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	6	our	PRP$	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	7	knowledge	NN	*)	-	-	-	-	*	-
en_1032.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	10	mechanisms	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	12	action	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	14	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	15	supplements	NNS	*))))))))))	-	-	-	-	*	-
en_1032.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Basic	NNP	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	1	issues	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	2	concerning	VBG	(VP*	-	-	-	-	*	-
en_1032.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	4	efficacy	NN	*	-	-	-	-	*	-
en_1032.txt	0	5	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	6	safety	NN	*)	-	-	-	-	*	-
en_1032.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	8	consuming	NN	(NP*)))	-	-	-	-	*	-
en_1032.txt	0	9	relatively	RB	(NP(NP(ADJP*	-	-	-	-	*	-
en_1032.txt	0	10	high	JJ	*)	-	-	-	-	*	-
en_1032.txt	0	11	doses	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	13	antioxidant	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	14	supplements	NNS	*)))))	-	-	-	-	*	-
en_1032.txt	0	15	need	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	16	to	TO	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	17	be	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	18	resolved	VBN	(VP*)))))	-	-	-	-	*	-
en_1032.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	Results	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	1	of	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	2	ongoing	JJ	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	3	clinical	JJ	*	-	-	-	-	*	-
en_1032.txt	0	4	trials	NNS	*)	-	-	-	-	*	-
en_1032.txt	0	5	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	6	further	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	7	studies	NNS	*))))	-	-	-	-	*	-
en_1032.txt	0	8	are	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	9	required	VBN	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	11	improve	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	12	our	PRP$	(NP*	-	-	-	-	*	(12)
en_1032.txt	0	13	knowledge	NN	*))))))	-	-	-	-	*	-
en_1032.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_1032.txt	0	2	meantime	NN	*))	-	-	-	-	*	-
en_1032.txt	0	3	,	,	*	-	-	-	-	*	-
en_1032.txt	0	4	we	PRP	(NP*)	-	-	-	-	*	(12)
en_1032.txt	0	5	know	VBP	(VP*	-	-	-	-	*	-
en_1032.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_1032.txt	0	7	antioxidants	NNS	(S(NP*)	-	-	-	-	*	-
en_1032.txt	0	8	can	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	9	cause	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	unwanted	JJ	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	health	NN	*	-	-	-	-	*	-
en_1032.txt	0	12	consequences	NNS	*))))))	-	-	-	-	*	-
en_1032.txt	0	13	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	So	IN	(TOP(S*	-	-	-	-	*	-
en_1032.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_1032.txt	0	2	optimal	JJ	*	-	-	-	-	*	-
en_1032.txt	0	3	source	NN	*)	-	-	-	-	*	-
en_1032.txt	0	4	for	IN	(PP*	-	-	-	-	*	-
en_1032.txt	0	5	antioxidants	NNS	(NP*)))	-	-	-	-	*	-
en_1032.txt	0	6	is	VBZ	(VP*	-	-	-	-	*	-
en_1032.txt	0	7	diet	NN	(NP(NP*)	-	-	-	-	*	-
en_1032.txt	0	8	,	,	*	-	-	-	-	*	-
en_1032.txt	0	9	not	RB	*	-	-	-	-	*	-
en_1032.txt	0	10	supplements	NNS	(NP*)))	-	-	-	-	*	-
en_1032.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1032.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1032.txt	0	1	short	JJ	(NP*))	-	-	-	-	*	-
en_1032.txt	0	2	,	,	*	-	-	-	-	*	-
en_1032.txt	0	3	we	PRP	(NP*)	-	-	-	-	*	-
en_1032.txt	0	4	should	MD	(VP*	-	-	-	-	*	-
en_1032.txt	0	5	stop	VB	(VP(VP*	-	-	-	-	*	-
en_1032.txt	0	6	taking	VBG	(S(VP*	-	-	-	-	*	-
en_1032.txt	0	7	pills	NNS	(NP*))))	-	-	-	-	*	-
en_1032.txt	0	8	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	9	eat	VB	(VP*	-	-	-	-	*	-
en_1032.txt	0	10	more	JJR	(NP*	-	-	-	-	*	-
en_1032.txt	0	11	fruits	NNS	*	-	-	-	-	*	-
en_1032.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1032.txt	0	13	vegetables	NNS	*))))	-	-	-	-	*	-
en_1032.txt	0	14	.	.	*))	-	-	-	-	*	-

#end document
